Health
Results: 37-48 of 8661

Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA

Implantica announces new breakthrough long-term RefluxStop® data on severe sufferers presented at DDW 2026

BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

Avid Bioservices Appoints Maria Ebro Andreasen as Chief People Officer to Fuel Continued Growth and Talent Strategy




